Open- | Close- |
Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
Day Range- - - | 52 Wk Range0.770 - 1.790 |
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
Day Range- - - | 52 Wk Range0.770 - 1.790 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.290 | -0.320 | -0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ASMB | Assembly Biosciences | -1.13% | 46M |
AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
HOOK | HOOKIPA Pharma | 0% | 51.7M |
GANX | Gain Therapeutics | 14.94% | 47.9M |
CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
There is no dividend information for Assembly Biosciences.
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Assembly Biosciences.
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
Day Range- - - | 52 Wk Range0.770 - 1.790 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.290 | -0.320 | -0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ASMB | Assembly Biosciences | -1.13% | 46M |
AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
HOOK | HOOKIPA Pharma | 0% | 51.7M |
GANX | Gain Therapeutics | 14.94% | 47.9M |
CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
There is no dividend information for Assembly Biosciences.
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Assembly Biosciences.
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
Day Range- - - | 52 Wk Range0.770 - 1.790 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.290 | -0.320 | -0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ASMB | Assembly Biosciences | -1.13% | 46M |
AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
HOOK | HOOKIPA Pharma | 0% | 51.7M |
GANX | Gain Therapeutics | 14.94% | 47.9M |
CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
There is no dividend information for Assembly Biosciences.
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Assembly Biosciences.
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
Day Range- - - | 52 Wk Range0.770 - 1.790 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.290 | -0.320 | -0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ASMB | Assembly Biosciences | -1.13% | 46M |
AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
HOOK | HOOKIPA Pharma | 0% | 51.7M |
GANX | Gain Therapeutics | 14.94% | 47.9M |
CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
There is no dividend information for Assembly Biosciences.
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Assembly Biosciences.
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
Day Range- - - | 52 Wk Range0.770 - 1.790 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.290 | -0.320 | -0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ASMB | Assembly Biosciences | -1.13% | 46M |
AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
HOOK | HOOKIPA Pharma | 0% | 51.7M |
GANX | Gain Therapeutics | 14.94% | 47.9M |
CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
There is no dividend information for Assembly Biosciences.
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Assembly Biosciences.
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
Day Range- - - | 52 Wk Range0.770 - 1.790 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.290 | -0.320 | -0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ASMB | Assembly Biosciences | -1.13% | 46M |
AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
HOOK | HOOKIPA Pharma | 0% | 51.7M |
GANX | Gain Therapeutics | 14.94% | 47.9M |
CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
There is no dividend information for Assembly Biosciences.
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Assembly Biosciences.
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
Day Range- - - | 52 Wk Range0.770 - 1.790 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.290 | -0.320 | -0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ASMB | Assembly Biosciences | -1.13% | 46M |
AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
HOOK | HOOKIPA Pharma | 0% | 51.7M |
GANX | Gain Therapeutics | 14.94% | 47.9M |
CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
There is no dividend information for Assembly Biosciences.
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Assembly Biosciences.
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
Day Range- - - | 52 Wk Range0.770 - 1.790 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.290 | -0.320 | -0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ASMB | Assembly Biosciences | -1.13% | 46M |
AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
HOOK | HOOKIPA Pharma | 0% | 51.7M |
GANX | Gain Therapeutics | 14.94% | 47.9M |
CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
There is no dividend information for Assembly Biosciences.
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Assembly Biosciences.
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Assembly Biosciences Stock (NASDAQ: ASMB) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 97.794K | Mkt Cap46.037M |
Day Range- - - | 52 Wk Range0.770 - 1.790 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.290 | -0.320 | -0.0300 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-03-24 | HC Wainwright & Co. | Ed Arce | Maintains | Neutral | Lowers | 2.50 | 1.50 |
2022-11-16 | Mizuho | Salim Syed | Maintains | Buy | Lowers | 14.00 | 3.00 |
2022-10-24 | Truist Securities | Nicole Germino | Downgrades | BuyHold | Lowers | 11.00 | 2.00 |
2022-04-01 | Truist Securities | Nicole Germino | Maintains | Buy | Lowers | 15.00 | 12.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ASMB | Assembly Biosciences | -1.13% | 46M |
AGLE | Aeglea BioTherapeutics | -4.65% | 47.3M |
HOOK | HOOKIPA Pharma | 0% | 51.7M |
GANX | Gain Therapeutics | 14.94% | 47.9M |
CNTB | Connect Biopharma Hldgs | -9.1% | 41M |
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Other companies in Assembly Biosciences’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), HOOKIPA Pharma (NASDAQ:HOOK), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to rise to within 12 months (a possible 71.43% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $0.875 last updated September 27, 2023 at 9:21 PM UTC.
There is no dividend information for Assembly Biosciences.
Assembly Biosciences’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Assembly Biosciences.
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.